Materialise NV (NASDAQ: MTLS), a prominent provider of additive manufacturing and medical software alongside sophisticated 3D printing services, disclosed its financial outcomes for the second quarter ending June 30, 2025. The company reported a decline in total consolidated revenue by 5.8%, reaching €64.8 million compared to the same period in 2024. This decline was primarily driven by a decrease in revenues from its Software and Manufacturing segments, which fell by 12.1% and 24.9% respectively. In contrast, the Materialise Medical segment showcased robust growth, increasing by 16.7% from the previous year. Despite the revenue pressures, Materialise improved its gross profit margin to 58.3%, up from 57.0% during the same quarter last year. However, Adjusted EBIT for the quarter was €3.1 million, lower than the €3.9 million recorded in the corresponding period of 2024. Looking ahead, Materialise has slightly reduced its revenue guidance for the full fiscal year 2025, now anticipating a range of €265 million to €280 million. The company attributes this adjustment to potential geo-political volatility and macro-economic uncertainties, as well as unfavorable foreign exchange fluctuations. Nevertheless, Materialise maintains its Adjusted EBIT guidance between €6 million and €10 million for the year, emphasizing its commitment to operational profitability through structural cost efficiencies.